Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric material wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable of expanding at body temperature in a body lumen from a crimped configuration to a deployed diameter and will have sufficient strength to support a body lumen when expanded.

Abstract: A touchpad and an electronic device are disclosed. The touchpad includes a touch panel; a plurality of pressure sensors fixed to an elastic bracket and configured to detect a pressure applied on the touch panel; a piezoelectric ceramic assembly including a piezoelectric ceramic plate configured to provide a vibration feedback to a user, where the piezoelectric ceramic assembly is fixed below the touch panel in a suspended manner and spaced from the elastic bracket.

Abstract: The present disclosure provides an ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root, comprising the following steps: S1, material treatment, S2, cold soaking, S3 enzymatic hydrolysis, S4 extract extraction, and S5 ultrasonic-microwave synergistic extraction. The extraction method of the present disclosure extracts relatively high content of total saponins, and has relatively high yield of saponins and low content of impurities, and each step acts synergistically to solve the problems of relatively low total saponin content, more impumayrities and bubbling in the extraction process.

Abstract: The invention disclosed herein relates to aza-quinoline compounds of Formula (I), pharmaceutical compositions comprising such compounds, and the use of such compounds for treating a disease or condition mediated by Enhancer of Zeste Homolog 2 (EZH2), Polycomb Repressive Complex 2 (PRC2), or a combination thereof.

Abstract: The present disclosure provides an ultrasonic-microwave synergistic extraction method of total saponins in beautiful millettia root, comprising the following steps: S1, material treatment, S2, cold soaking, S3 enzymatic hydrolysis, S4 extract extraction, and S5 ultrasonic-microwave synergistic extraction. The extraction method of the present disclosure extracts relatively high content of total saponins, and has relatively high yield of saponins and low content of impurities, and each step acts synergistically to solve the problems of relatively low total saponin content, more impumayrities and bubbling in the extraction process.

Abstract: Disclosed are a collision check data processing method and apparatus, an electronic device, and a storage medium. The method comprises: acquiring generated collision check data, and acquiring an ID number of a collision part according to the collision check data; then acquiring ID numbers corresponding to selected designated parts from a preset database; and determining a target part under collision according to the ID numbers corresponding to the designated parts and the ID number of the collision part. According to the disclosure, a target part under collision can be determined among large amounts of collision check data according to an ID number corresponding to a designated part and an ID number of a collision part. That is, according to the disclosure, a single item among the collision check data can be checked according to a user requirement, thereby improving the check efficiency effectively.

Abstract: Provided aza-quinoline compounds of Formula (I), pharmaceutical compositions comprising such compounds; and the use of such compounds for treating a disease or condition mediate by Enhancer of Zeste Homolog 2 (EZH2), Polycomb Repressive Complex 2 (PRC2), or a combination thereof.

Abstract: A touchpad and an electronic device are disclosed. The touchpad includes a touch panel; a plurality of pressure sensors fixed to an elastic bracket and configured to detect a pressure applied on the touch panel; a piezoelectric ceramic assembly including a piezoelectric ceramic plate configured to provide a vibration feedback to a user, where the piezoelectric ceramic assembly is fixed below the touch panel in a suspended manner and spaced from the elastic bracket.

Abstract: Disclosed are a collision check data processing method and apparatus, an electronic device, and a storage medium. The method comprises: acquiring generated collision check data, and acquiring an ID number of a collision part according to the collision check data; then acquiring ID numbers corresponding to selected designated parts from a preset database; and determining a target part under collision according to the ID numbers corresponding to the designated parts and the ID number of the collision part. According to the disclosure, a target part under collision can be determined among large amounts of collision check data according to an ID number corresponding to a designated part and an ID number of a collision part. That is, according to the disclosure, a single item among the collision check data can be checked according to a user requirement, thereby improving the check efficiency effectively.

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

Abstract: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).